Micro Needle. Macro Benefits.

Micro Needle. Macro Benefits.

Improved immunogenecity and dose sparing

Improved immunogenicity and
dose sparing

Our extensive clinical trials have shown improved immunogenicity and dose sparing over both intramuscular1-7,10 and subcutaneous8 delivery, as well as over intradermal delivery using the Mantoux technique3

read more
Smallest hollow needle In the market

Smallest hollow needle in
the market

MicronJet600 microneedle allows for a nearly painless injection8-9. When it comes to microneedles, less is more

read more
Shallowest, most consistent ID delivery

Shallowest, most consistent intradermal delivery

Due to its unique design the MicronJet600 microneedle is one of most shallow and most consistent4-9 forms of intradermal delivery

read more

Extensive Clinical Experience

Numerous Trials

NanoPass’ MicronJet600 was already used to administer over 22,000 injections to approximately 4,200 patients in more than 45 completed and ongoing clinical trials

read more

Validated Benefits

MicronJet600 has demonstrated a superior immune response with full dose2,3,5 and equivalence or a trend for superiority with lower doses (4-40%)1-8,10

read more

Patented Technology

Intradermal delivery

Intradermal vaccine delivery has been repeatedly shown to allow significant dose sparing when compared to conventional administration methods**

read more
Patented Technology

Robust design

NanoPass MicronJet600 microneedles are based on MEMS (Micro electro mechanical Systems) technology and are made of pure silicon crystal

read more

Video Gallery

How to perform a MicronJet600 injection

The beauty of a MicronJet600 injection into the air

About NanoPass

NanoPass Technologies Ltd. is a pioneer in the development and commercialization of nearly painless intradermal delivery solutions for vaccines and drugs. Its flagship product, the 0.6mm MicronJet600 microneedle, is the first and only true (<1mm) microneedle to receive FDA clearance as an intradermal delivery device for substances approved for delivery below the surface of the skin

read more
about nanopass

*See references
**Darin Zehrung et al. intradermal delivery for vaccine dose sparing: overview of current issues. Vaccine 31 (2013) 3392-3395